chr20-53571850-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_006526.3(ZNF217):āc.3041A>Gā(p.Lys1014Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000049 in 1,591,798 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00028 ( 0 hom., cov: 30)
Exomes š: 0.000025 ( 0 hom. )
Consequence
ZNF217
NM_006526.3 missense
NM_006526.3 missense
Scores
6
13
Clinical Significance
Conservation
PhyloP100: 3.26
Genes affected
ZNF217 (HGNC:13009): (zinc finger protein 217) Enables DNA-binding transcription repressor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Involved in negative regulation of transcription by RNA polymerase II. Located in mitochondrion and nuclear speck. Part of histone deacetylase complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High AC in GnomAd4 at 42 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF217 | NM_006526.3 | c.3041A>G | p.Lys1014Arg | missense_variant | 5/6 | ENST00000371471.7 | NP_006517.1 | |
LOC101927770 | NR_110051.1 | n.788-798T>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF217 | ENST00000371471.7 | c.3041A>G | p.Lys1014Arg | missense_variant | 5/6 | 5 | NM_006526.3 | ENSP00000360526 | P1 | |
ZNF217 | ENST00000302342.3 | c.3041A>G | p.Lys1014Arg | missense_variant | 4/5 | 1 | ENSP00000304308 | P1 | ||
ENST00000424252.2 | n.788-798T>C | intron_variant, non_coding_transcript_variant | 2 | |||||||
ZNF217 | ENST00000437222.1 | c.302-2586A>G | intron_variant | 2 | ENSP00000394010 |
Frequencies
GnomAD3 genomes AF: 0.000278 AC: 42AN: 151118Hom.: 0 Cov.: 30
GnomAD3 genomes
AF:
AC:
42
AN:
151118
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000763 AC: 17AN: 222670Hom.: 0 AF XY: 0.0000496 AC XY: 6AN XY: 120930
GnomAD3 exomes
AF:
AC:
17
AN:
222670
Hom.:
AF XY:
AC XY:
6
AN XY:
120930
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000250 AC: 36AN: 1440562Hom.: 0 Cov.: 30 AF XY: 0.0000307 AC XY: 22AN XY: 716372
GnomAD4 exome
AF:
AC:
36
AN:
1440562
Hom.:
Cov.:
30
AF XY:
AC XY:
22
AN XY:
716372
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000278 AC: 42AN: 151236Hom.: 0 Cov.: 30 AF XY: 0.000284 AC XY: 21AN XY: 73940
GnomAD4 genome
AF:
AC:
42
AN:
151236
Hom.:
Cov.:
30
AF XY:
AC XY:
21
AN XY:
73940
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
6
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
11
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 18, 2023 | The c.3041A>G (p.K1014R) alteration is located in exon 4 (coding exon 4) of the ZNF217 gene. This alteration results from a A to G substitution at nucleotide position 3041, causing the lysine (K) at amino acid position 1014 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
P;P
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AG_spliceai
Position offset: -1
Find out detailed SpliceAI scores and Pangolin per-transcript scores at